Allspring Global Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Allspring Global Investments's PFE Position: Q2 2026 in Review
Allspring Global Investments increased its Pfizer (PFE) stake by 64% in Q2 2026, buying an estimated $10.4M and bringing the position to 1,019,768 shares worth $24.4M. The position accounts for 0.04% of the portfolio, ranked #515.
Allspring Global Investments first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $262M in Q4 2021. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Allspring Global Investments held 1,019,768 shares of Pfizer worth $24.4M as of Q2 2026.
- Allspring Global Investments bought 399,171 Pfizer shares in Q2 2026, an estimated $10.4M.
- Pfizer made up 0.04% of Allspring Global Investments's portfolio in Q2 2026, its #515 holding.
- Allspring Global Investments first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Pfizer position peaked at $262M in Q4 2021.
- 2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.